Austarpharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUSTARPHARMA, and what generic and branded alternatives to AUSTARPHARMA drugs are available?
AUSTARPHARMA has three approved drugs.
Drugs and US Patents for Austarpharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Austarpharma | SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 210281-002 | May 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Austarpharma | FENOFIBRATE | fenofibrate | TABLET;ORAL | 207803-001 | Dec 19, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Austarpharma | FENOFIBRATE | fenofibrate | TABLET;ORAL | 208476-002 | Feb 10, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.